Statements of Changes in Stockholders' Deficit - 10 months ended Dec. 31, 2021 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2021
Beginning balance, shares at Feb. 28, 2021
Issuance of common stock to founders for cash	$ 288	24,712		25,000
Issuance of common stock to founders for cash, shares	2,875,000
Capital contribution for transfer of founder shares to directors and advisors	$ (34)			34
Capital contribution for transfer of founder shares to directors and advisors, shares	(337,576)
Sale of shares to directors and advisors	$ 34			(34)
Sale of shares to directors and advisors, shares	337,576
Sale of 10,900,000 private placement warrants		5,450,000		5,450,000
Deposit to Trust Account from private placement		(1,150,000)		(1,150,000)
Proceeds from private placement warrants classified as equity		2,357,500		2,357,500
Offering costs allocated to public warrants classified as equity		(136,008)		(136,008)
Offering costs allocated to private placement warrants classified as equity		(314,420)		(314,420)
Accretion of common stock to redemption value		(6,231,784)	(2,624,257)	(8,856,041)
Net loss			(314,972)	(314,972)
Ending balance, value at Dec. 31, 2021	$ 288		$ (2,939,229)	$ (2,938,941)
Ending balance, shares at Dec. 31, 2021	2,875,000